Pharmalot recently covered the American College of Obstetricians and Gynecologists statement that birth control should be provided over the counter. There are lots of reasons why it makes sense according to their research, including increasing usage among those populations that need it, and increasing adherence. It stands to reason that if you remove an obstacle for [...]
Since our recent launch of Treato Pharma at Health 2.0, we’ve been getting lots of attention from digital marketing agencies and pharma companies. Most recently, Simon Smith, the passionate digital strategist from Klick Health, reviewed Treato and Treato Pharma in his article “Can Treato make social listening safe (and useful) for pharma?” He explains how [...]
Hearing the “Patient Voice” is a critical element in understanding how real users of prescription medications – the end customers – feel about them. When gathering brand intelligence, there are several methods for incorporating patient experiences – surveys, focus groups, and in recent years, social media. Surveys Typically administered over the phone or more recently [...]
by Gideon Mantel, CEO & co-founder and Ido Hadari, President Health 2.0 is flying by – here are some more observations now that the conference is in full swing. It’s been great to meet so many old friends. This year, we have held most of our meetings in a hospitality suite, which gives us the advantage [...]
John Mack, aka Pharmaguy, kicked off Day 2 of Health 2.0 by interviewing Treato’s CEO and co-founder Gideon Mantel about real time patient intelligence on his Pharma Marketing podcast. In the interview, Gideon talks about just how big Treato’s definition of big data is, what the difference is between Treato.com (advertising-free site for patients) and Treato [...]
Health 2.0 started yesterday, and here are some initial thoughts and observations based on the iPharma session in which we participated. Around 400 people came to the six pre-conference events, one of which was the iPharma session. Marco Smit from #health2con opened the iPharma session with a quick survey of the 50-60 people in the [...]
Just in case you missed the Google alert, tweet, LinkedIn or Facebook notification, it’s now official – the new, professional version of Treato, aka Treato Pharma, is available. Treato Pharma interprets vasts amounts of patient experiences from blogs and forums into an efficient, user-friendly format for pharmaceutical marketers and agencies, to enable them to incorporate [...]
Treato’s CEO and co-founder Gideon Mantel reveals some of Treato’s recent research on how clinical trials are discussed in social media in an article on Pharmaphorum. Turns out that every stage 3 trial is already being discussed in social media, and some much earlier than stage 3. It’s not always the participants however, logging [...]
I was intrigued by a recent post on Pharmalot, summarizing an extensive report by Communications Media that surveyed over 600 physicians about what they would like to receive from pharmaceutical companies. By far the largest group of respondents answered “None/ Don’t Know.” Since so many peopled answered this way, of course the natural follow up [...]
If you’re of a certain age, a “teaspoon” in dosing parlance meant exactly that: the spoon your mom used to give you your medicine was the same stainless steel spoon with which you ate your cereal. A teaspoon was a teaspoon. I was recently reminded of those days. I can still taste a ground up [...]
